Adeyelu Asekun
Biographic Data
| ID | 9075968 |
|---|---|
| NAME | Adeyelu Asekun |
| GIVEN NAMES | Adeyelu |
| FAMILY NAME | Asekun |
| SIGNATURE | ASEKUN A |
| AFFILIATIONS | Centers for Disease Control and Prevention |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Implementation of data triangulation and dashboard development for Covid-19 vaccine adverse event following immunisation (Aefi) data in Nigeria
Nigeria began administering COVID-19 vaccines on 5 March 2021 and is working towards the WHO’s African regional goal to fully vaccinate 70% of their eligible population by December 2022. Nigeria’s COVID-19 vaccination information system includes a surveillance system for COVID-19 adverse events following immunisation (AEFI), but as of April 2021, AEFI data were being collected and managed by multiple groups and lacked routine analysis and use for…
Barriers and facilitators to hepatitis B birth dose vaccination
Nigeria is estimated to have the largest number of children worldwide, living with chronic hepatitis B virus (HBV) infection, the leading cause of liver cancer. Up to 90% of children infected at birth develop chronic HBV infection. A birth dose of the hepatitis B vaccine (HepB-BD) followed by at least two additional vaccine doses is recommended for prevention. This study assessed barriers and facilitators of HepB-BD administration and uptake, usi…
No prominent works on this page.
Implementation of data triangulation and dashboard development for Covid-19 vaccine adverse event following immunisation (Aefi) data in Nigeria
Nigeria began administering COVID-19 vaccines on 5 March 2021 and is working towards the WHO’s African regional goal to fully vaccinate 70% of their eligible population by December 2022. Nigeria’s COVID-19 vaccination information system includes a surveillance system for COVID-19 adverse events following immunisation (AEFI), but as of April 2021, AEFI data were being collected and managed by multiple groups and lacked routine analysis and use for…
Barriers and facilitators to hepatitis B birth dose vaccination
Nigeria is estimated to have the largest number of children worldwide, living with chronic hepatitis B virus (HBV) infection, the leading cause of liver cancer. Up to 90% of children infected at birth develop chronic HBV infection. A birth dose of the hepatitis B vaccine (HepB-BD) followed by at least two additional vaccine doses is recommended for prevention. This study assessed barriers and facilitators of HepB-BD administration and uptake, usi…
Medicine (2 works) · Vaccine Coverage and Hesitancy (2 works) · Business (1 work) · Cartography (1 work) · Computer Science (1 work) · COVID-19 epidemiological studies (1 work) · Dashboard (1 work) · Data science (1 work) · Family medicine (1 work) · Geography (1 work)